Hi Mike,
I've seen that 30% false negative statistic too.
Of course it depends on what it is based on: the kind of biopsy (old-style 6 core, newer 5 region (usually 12 core), "saturation" ranging from 15 to around 24, "3D mapping" with a sample every 5 mm throughout the prostate (that's definitely saturation, with an average per Dr. Onik's initial 110 patients of 46 sticks!), whether guided by TRUS (Trans Rectal UltraSound) or color Doppler TRUS (or neither!), the size of the prostate and BPH status, the nature of the cancer (such as cases caught early, late, all comers, varying in extent of cancer, shape and location), DRE status, PSA and PSA velocity, free PSA results, PCA3Plus results, previous biopsy or not, finasteride (and probably
Avodart) use, and probably some other factors.
One study of the 3D Mapping saturation biopsy technique indicates 95% accuracy in detecting clinically significant cancers. While not as good, color Doppler TRUS guided biopsies should also achieve better results than 30% false negatives.
Do you want more detail on Dr. Onik's technique and results, with his comments on other types of biopsies? I've got the workbook with vugraphs from his talk at the International Conference on Prostate Cancer 2006, held in Reston, Virginia.
If you go to the Government site [url]www.pubmed.gov[/url], you can find studies that look at the issue of false negatives in prostate biopsies.
Jim